Securing Drug R&D IP & Clinical Operations
Safeguarding valuable pharmaceutical patents, clinical trial databases (EDC/eCRF), lab automation systems (LIMS), and batch manufacturing lines against industrial espionage, ransomware, and regulatory sanctions.
Pharma Security Profile
The Life Sciences & Pharma Attack Surface
Multi-million dollar drug patents, sensitive clinical trial data, and automated manufacturing lines make pharmaceuticals a prime target for nation-states and extortion groups.
Drug Blueprint & Patent Theft
Advanced Persistent Threats (APTs) targeting R&D lab servers to exfiltrate proprietary molecular formulas, gene sequencing data, and patent blueprints.
Clinical Trial Data Tampering & Breach
Breaches in Electronic Data Capture (EDC) systems and Clinical Trial Management Systems (CTMS) exposing patient PII and compromising trial integrity.
Ransomware on Batch Manufacturing Lines
Targeted ransomware encrypting SCADA, Historian, and PLC systems in active pharmaceutical ingredient (API) manufacturing plants, halting production.
Laboratory Automation & LIMS Exploitation
Unpatched vulnerabilities across Laboratory Information Management Systems (LIMS) and automated spectroscopy equipment compromising test results.
Cold Chain & IIoT Sensor Manipulation
Cyber attacks targeting cold-chain IoT temperature sensors, causing false readings that spoil biological drugs and vaccine shipments.
CRO & Vendor Supply Chain Risks
Third-party Contract Research Organizations (CROs), CMOs, and logistics partners introducing indirect attack vectors into core pharma networks.
Why Cybersecurity is Critical for Pharmaceuticals
In pharmaceuticals, a cyber incident jeopardizes multi-year R&D investments, batch quality, and global regulatory approvals.
Loss of Multi-Million Dollar R&D IP
Stolen molecular designs or drug formulas allow competitor nations or counterfeiters to bring generic drugs to market prematurely.
FDA & Regulatory Warning Letters
System compromise violating US FDA 21 CFR Part 11 or EU Annex 11 leads to immediate batch holds, import bans, and regulatory sanctions.
Batch Spoilage & Plant Downtime
Ransomware locking down manufacturing automation spoils active chemical batches, costing millions in wasted ingredients and downtime.
Clinical Trial Invalidation
Tampered trial result logs force trial halts, requiring costly trial repeats and delaying life-saving drug launches by years.
Heavy Fines Under DPDP Act 2023
Severe penalties for failing to protect patient identity data recorded during phase I-IV clinical trials across hospital testing sites.
Loss of Commercial Partner Trust
Breaches in CRO or CMO networks result in contract cancellations, loss of licensing deals, and market valuation decline.
Pharma & Life Sciences Security Services
Specialized security assessments engineered to safeguard clinical data, lab systems, and automated production facilities.
R&D IP & Clinical Trial Platform Security
EDC & CTMS Application VAPT
Deep penetration testing of Electronic Data Capture and trial management portals against BOLA, injection, and privilege escalation.
R&D Database Hardening & Encryption Audit
Auditing access controls, data-at-rest encryption, and DLP policies safeguarding proprietary chemical compound formulas.
Secure Code Review for HealthTech & Diagnostic Software
Line-by-line static source code analysis for companion diagnostic apps and medical algorithm software.
LIMS & Laboratory System Security
LIMS & ELN Security Assessment
Auditing Laboratory Information Management Systems and Electronic Lab Notebooks against unauthorized test parameter modification.
Automated Lab Equipment Firmware Audit
Assessing security posture and unpatched vulnerabilities in networked lab spectrometers, centrifuges, and analyzers.
Pharma Plant & OT Manufacturing Security
Pharma Plant SCADA & PLC Security Audit
Non-intrusive safety-first security assessment of PLCs, HMIs, and batch control systems in chemical processing units.
IT/OT Convergence & iDMZ Segmentation
Validating Purdue Model network isolation between corporate ERP networks and cleanroom production lines.
FDA 21 CFR Part 11 & Regulatory Alignment
US FDA 21 CFR Part 11 Security Audit
Auditing electronic signatures, audit trail integrity, and access logging for regulatory submission systems.
GxP Computer System Validation (CSV) Support
Security risk assessments mapping directly to GAMP 5 and Good Automated Manufacturing Practice standards.
DPDP Act 2023 Clinical Trial Data Privacy Review
Mapping patient consent workflows and anonymization controls for clinical research data.
R&D & Clinical Staff Cyber Awareness
Scientist & R&D Staff Phishing Simulations
Simulated social engineering campaigns targeting research scientists, lab managers, and clinical monitors.
IP Protection & Clean Desk Training
Educating laboratory personnel on USB drive hygiene, physical access security, and safe data handling.
Staarken's Pharma Security Workflow
An 8-stage methodology designed specifically for life sciences, prioritizing data integrity, zero batch disruption, and GxP compliance.
Discovery & Scoping
Mapping R&D databases, EDC portals, LIMS systems, manufacturing PLCs, and scoping parameters.
GxP Threat Modeling
Analyzing drug formula data flows, audit trails, and batch execution systems to map attack vectors.
Passive & Active Assessment
Combining automated vulnerability scanning with manual penetration testing across IT and OT zones.
Controlled Validation
Verifying findings in staging environments or during scheduled maintenance without affecting live batches.
Regulatory Impact Analysis
Translating technical flaws into FDA warning risks, patent leakage exposure, and clinical data impact.
Executive & Quality Reporting
Delivering board-level dashboards alongside CVSS-scored technical findings for Quality & IT leads.
Remediation Guidance & Retest
Providing developer code fixes and OT compensating controls followed by formal verification retesting.
Continuous Partnership
Ongoing threat intelligence, periodic reassessments, and regulatory update advisories for global markets.
About Staarken Infosec
Empowering life science innovators with practitioner-led cybersecurity, advanced research, and dedicated risk management.
Founded
Established with a mission to advance cybersecurity research, practical training, and offensive security capabilities.
Engineers Trained
Built deep industry credibility by training thousands of engineers in application security and secure coding.
Enterprise & OT VAPT
Expanded into enterprise-grade security assessments across pharma, healthtech, and manufacturing sectors.
Pharma Partner
Partnering with life sciences organizations to protect drug IP, secure clinical trials, and ensure regulatory compliance.
Pharma Engagement Deliverables
Audit-ready, practical deliverables designed for Board Leadership, CISOs, and Quality Assurance Teams.
Executive Risk Dashboard
High-level risk overview detailing IP exposure rating, GxP security posture, and priority recommendations.
Technical Audit Report
Comprehensive vulnerability breakdown, EDC/LIMS findings, CVSS ratings, and remediation code guidance.
Proof of Concept (PoC) Evidence
Validated proof of real-world exploitability demonstrating application logic flaws without compromising live trial data.
FDA 21 CFR Part 11 Gap Matrix
Actionable remediation roadmap mapped to electronic signature and audit trail compliance requirements.
Retest & GxP Compliance Certificate
Formal security verification certificate confirming bug resolution for regulatory auditors and commercial partners.